-
1دورية أكاديمية
المؤلفون: Aleksandra Urban, Johanne Hermansen, Yanping Yin, Weikaixin Kong, Rebecca Teglgaard, Christian Brieghel, Sabina Kersting, Geir E. Tjønnfjord, Mark-David Levin, Hoa T. T. Tran, Mattias Mattsson, Juha Ranti, Gerrit-Jan Veldhuis, Caspar Da Cunha-Bang, Rogier Mous, Julie Dubois, Arnon Kater, Carsten Niemann, Tero Aittokallio, Sigrid Skånland
المصدر: HemaSphere, Vol 7, p e92046ec (2023)
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
2
المؤلفون: Davide Rossi, Ritsuro Suzuki, Xavier Badoux, Eduardo Cervera Ceballos, Florence Cymbalista, Alexander Egle, Virginia Abello, Hoa T. T. Tran, Peter Hillmen, Stephen P. Mulligan, Jennifer R. Brown, William G. Wierda, Stephan Stilgenbauer, Yair Herishanu, Teoman Soysal, Andy C. Rawstron, Colin P. Diong, Carsten Utoft Niemann, Shang Ju Wu, Paolo Ghia, Carolyn Owen
المساهمون: Wierda, W. G., Rawstron, A., Cymbalista, F., Badoux, X., Rossi, D., Brown, J. R., Egle, A., Abello, V., Cervera Ceballos, E., Herishanu, Y., Mulligan, S. P., Niemann, C. U., Diong, C. P., Soysal, T., Suzuki, R., Tran, H. T. T., Wu, S. -J., Owen, C., Stilgenbauer, S., Ghia, P., Hillmen, P.
المصدر: Wierda, W G, Rawstron, A, Cymbalista, F, Badoux, X, Rossi, D, Brown, J R, Egle, A, Abello, V, Cervera Ceballos, E, Herishanu, Y, Mulligan, S P, Niemann, C U, Diong, C P, Soysal, T, Suzuki, R, Tran, H T T, Wu, S J, Owen, C, Stilgenbauer, S, Ghia, P & Hillmen, P 2021, ' Measurable residual disease in chronic lymphocytic leukemia : expert review and consensus recommendations ', Leukemia, vol. 35, no. 11, pp. 3059-3072 . https://doi.org/10.1038/s41375-021-01241-1
Leukemiaمصطلحات موضوعية: Chronic lymphocytic leukaemia, Cancer Research, medicine.medical_specialty, Consensus, Neoplasm, Residual, business.industry, Chronic lymphocytic leukemia, MEDLINE, Review Article, Hematology, Disease, Residual, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Minimal residual disease, Clinical trial, Medical research, Oncology, Chemoimmunotherapy, Practice Guidelines as Topic, Humans, Medicine, business, Intensive care medicine, Disease burden
وصف الملف: application/pdf
-
3
المؤلفون: Arnon P Kater, Mark-David Levin, Julie Dubois, Sabina Kersting, Lisbeth Enggaard, Gerrit J Veldhuis, Rogier Mous, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Johan A Dobber, Christian B Poulsen, Henrik Frederiksen, Ann Janssens, Ida Schjødt, Ellen C Dompeling, Juha Ranti, Christian Brieghel, Mattias Mattsson, Mar Bellido, Hoa T T Tran, Kazem Nasserinejad, Carsten U Niemann
المساهمون: Hematology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Human Genetics, ARD - Amsterdam Reproduction and Development
المصدر: The Lancet Oncology, 23(6), 818-828. Lancet Publishing Group
Kater, A P, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, van der Kevie-Kersemaekers, A-M F, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Brieghel, C, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Niemann, C U 2022, ' Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION) : primary analysis of an open-label, randomised, phase 2 trial ', The Lancet Oncology, vol. 23, no. 6, pp. 818-828 . https://doi.org/10.1016/S1470-2045(22)00220-0
Lancet Oncology, 23(6), 818-828. ELSEVIER SCIENCE INC
The Lancet. Oncology, 23(6), 818-828. Lancet Publishing Groupمصطلحات موضوعية: Sulfonamides, BCL2, Neoplasm, Residual, Adenine, PROLIFERATION, MULTICENTER, Bridged Bicyclo Compounds, Heterocyclic, BCR, Leukemia, Lymphocytic, Chronic, B-Cell, 1ST-LINE TREATMENT, Pyrimidines, Piperidines, Oncology, Antineoplastic Combined Chemotherapy Protocols, CYCLOPHOSPHAMIDE, CELLS, Humans, Pyrazoles, RITUXIMAB, FLUDARABINE, CLL
وصف الملف: application/pdf
-
4
المؤلفون: Mark-David Levin, Julie Dubois, Rogier Mous, Ellen C Dompeling, Hoa T. T. Tran, Mar Bellido, Christian Bjørn Poulsen, Juha Ranti, Sabina Kersting, Ida Schjødt, Arnon P. Kater, Ann Janssens, Henrik Frederiksen, Clemens Mellink, Johan A. Dobber, Mattias Mattsson, Carsten Utoft Niemann, Lisbeth Enggaard, Gerrit J Veldhuis, Kazem Nasserinejad
المساهمون: Hematology, Human Genetics, AII - Cancer immunology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life
المصدر: Blood, 137(8), 1117-1120. AMER SOC HEMATOLOGY
Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608
Blood, 137(8), 1117-1120. American Society of Hematology
Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608مصطلحات موضوعية: Oncology, medicine.medical_specialty, Science & Technology, Venetoclax, business.industry, Chronic lymphocytic leukemia, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, 1ST-LINE TREATMENT, chemistry.chemical_compound, chemistry, Ibrutinib, Internal medicine, Relapsed refractory, medicine, RITUXIMAB, business, Life Sciences & Biomedicine
وصف الملف: application/pdf; Print
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc9ad8a3176dac8f8c391574fbbaa55
https://hdl.handle.net/11370/98d01a12-fd30-4fee-916b-cdd713c9d5b3 -
5
المؤلفون: Rebecka Svanberg, Rogier Mous, Mattias Mattson, Arnon P. Kater, Sabina Kersting, Hoa T. T. Tran, Kazem Nasserinejad, Carsten Utoft Niemann, Sisse R. Ostrowski, Johan A. Dobber, Mark-David Levin
المساهمون: Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Hematology
المصدر: Leukemia & lymphoma, 61(14), 3422-3431. Informa Healthcare
Leukemia and Lymphoma, 61(14), 3422-3431. Informa Healthcareمصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Combination therapy, Chronic lymphocytic leukemia, medicine.medical_treatment, Targeted therapy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Piperidines, SDG 3 - Good Health and Well-being, ibrutinib, Internal medicine, Humans, Medicine, Adverse effect, Sulfonamides, medicine.diagnostic_test, venetoclax, business.industry, Venetoclax, Adenine, Hematology, Bridged Bicyclo Compounds, Heterocyclic, medicine.disease, bleeding, targeted therapy, Leukemia, Lymphocytic, Chronic, B-Cell, Thromboelastography, chemistry, 030220 oncology & carcinogenesis, Hemostasis, Ibrutinib, hemostasis, business, CLL, 030215 immunology
-
6
المؤلفون: Pål Andre Holme, Stine Bjørnsen, Nina Haagenrud Schultz, Carola E. Henriksson, Per Morten Sandset, Hoa T. T. Tran
المصدر: Research and Practice in Thrombosis and Haemostasis
مصطلحات موضوعية: medicine.medical_treatment, apixaban, recombinant factor VIIa, 030204 cardiovascular system & hematology, Pharmacology, 03 medical and health sciences, 0302 clinical medicine, Thrombin, medicine, 030212 general & internal medicine, Antidote, Whole blood, biology, business.industry, Original Articles, Hematology, Prothrombin complex concentrate, activated prothrombin complex concentrate, prothrombin complex concentrate, Thromboelastometry, Clotting time, Recombinant factor VIIa, biology.protein, Original Article, Apixaban, reversal, business, medicine.drug